Qube Research & Technologies Ltd - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 110 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$56,202
-69.4%
34,908
-37.7%
0.00%
-100.0%
Q4 2022$183,670
-16.5%
55,997
+136.6%
0.00%
-50.0%
Q1 2022$220,000
-27.9%
23,670
+20.7%
0.00%
-33.3%
Q2 2021$305,000
-74.0%
19,606
-76.0%
0.00%
-84.2%
Q1 2021$1,175,000
+32.3%
81,795
+80.9%
0.02%
+46.2%
Q4 2020$888,00045,2240.01%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Antipodean Advisors LLC 1,000,000$3,280,00010.95%
M28 Capital Management LP 439,300$1,440,9041.37%
Redmile Group, LLC 6,242,756$20,476,2400.84%
MAVERICK CAPITAL LTD 6,291,013$20,634,5230.49%
Baupost Group 8,123,616$26,6450.44%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 52,000$1710.25%
WASATCH ADVISORS LP 8,391,014$27,522,5250.18%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 525,000$1,722,0000.17%
STALEY CAPITAL ADVISERS INC 450,000$1,4760.09%
Virtus ETF Advisers LLC 36,100$118,4080.06%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders